VIA
PROK icon

Virtus Investment Advisers’s ProKidney PROK Stock Holding History

Virtus Investment Advisers’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
199,510
+76,122
+62% +$139K 0.09% 270
2026
Q1 		$221K Buy
123,388
+3,012
+3% +$6.39K 0.06% 329
2025
Q4 		$270K Buy
+120,376
New +$317K 0.07% 295

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtus Investment Advisers's PROK Position: Q2 2026 in Review

Virtus Investment Advisers increased its ProKidney (PROK) stake by 62% in Q2 2026, buying an estimated $139K and bringing the position to 199,510 shares worth $407K. The position accounts for 0.09% of the portfolio, ranked #270.

Virtus Investment Advisers first reported a position in PROK in Q4 2025 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Virtus Investment Advisers held 199,510 shares of ProKidney worth $407K as of Q2 2026.
  • Virtus Investment Advisers bought 76,122 ProKidney shares in Q2 2026, an estimated $139K.
  • ProKidney made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #270 holding.
  • Virtus Investment Advisers first reported a position in ProKidney in Q4 2025 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.